Sartorius AG (ADR)
General ticker "SOAGY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $74.2B (TTM average)
Sartorius AG (ADR) follows the US Stock Market performance with the rate: 36.5%.
Estimated limits based on current volatility of 0.9%: low 58.08$, high 59.14$
Factors to consider:
- Company pays dividends (annually): last record date 2025-03-31, amount 0.16$ (Y0.28%)
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [29.43$, 58.17$]
- 2025-12-31 to 2026-12-31 estimated range: [28.42$, 56.41$]
Financial Metrics affecting the SOAGY estimates:
- Negative: with PPE of 51.0 at the end of fiscal year the price was very high
- Positive: 7.86 < Operating profit margin, % of 12.93
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: 18.93 < Shareholder equity ratio, % of 27.37 <= 41.86
- Positive: 0.33 < Operating cash flow per share per price, % of 6.57
- Negative: Industry operating cash flow per share per price (median), % of 0.78 <= 5.52
- Positive: -2.95 < Return on assets ratio (scaled to [-100,100]) of 0.82
- Negative: Industry inventory ratio change (median), % of 1.55 > 0.28
- Positive: -8.75 < Industry operating profit margin (median), % of -7.19
Short-term SOAGY quotes
Long-term SOAGY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €4,174.70MM | €3,395.70MM | €3,380.70MM |
| Operating Expenses | €3,035.40MM | €2,851.80MM | €2,943.50MM |
| Operating Income | €1,139.30MM | €543.90MM | €437.20MM |
| Non-Operating Income | €42.40MM | €-157.90MM | €-250.40MM |
| Interest Expense | €35.20MM | €144.90MM | €184.10MM |
| R&D Expense | €213.00MM | €170.80MM | €196.80MM |
| Income(Loss) | €1,181.70MM | €386.00MM | €186.80MM |
| Taxes | €268.60MM | €95.90MM | €49.40MM |
| Profit(Loss)* | €913.10MM | €205.20MM | €84.00MM |
| Stockholders Equity | €1,989.80MM | €2,067.30MM | €2,764.80MM |
| Inventory | €1,179.10MM | €1,036.70MM | €788.50MM |
| Assets | €6,977.70MM | €9,755.30MM | €10,103.00MM |
| Operating Cash Flow | €734.20MM | €853.60MM | €976.20MM |
| Capital expenditure | €522.60MM | €559.70MM | €409.90MM |
| Investing Cash Flow | €-1,129.90MM | €-2,823.30MM | €-425.80MM |
| Financing Cash Flow | €209.90MM | €2,165.70MM | €-128.30MM |
| Earnings Per Share** | €2.67 | €0.60 | €0.24 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.